The prevalence and predictors of cognitive impairment in type 2 diabetic population of Punjab, India

Shallu Khullar; Gurpreet Kaur; Harjot Dhillon; Ritu Sharma; Kanchan Mehta; Monica Singh; Puneetpal Singh

doi:10.4103/2321-0656.193996

Journal of Social Health and Diabetes, Table of Contents

CC BY-NC-ND 4.0 · Journal of Social Health and Diabetes 2017; 05(01): 047-053
DOI: 10.4103/2321-0656.193996

Original Article

NovoNordisk Education Foundation

The prevalence and predictors of cognitive impairment in type 2 diabetic population of Punjab, India

Authors

Shallu Khullar

Department of Human Genetics, Punjabi University, Patiala, Punjab, India
Gurpreet Kaur

Department of Human Genetics, Punjabi University, Patiala, Punjab, India
Harjot Dhillon

Department of Human Genetics, Punjabi University, Patiala, Punjab, India
Ritu Sharma

Department of Human Genetics, Punjabi University, Patiala, Punjab, India
Kanchan Mehta

Department of Human Genetics, Punjabi University, Patiala, Punjab, India
Monica Singh

Department of Human Genetics, Punjabi University, Patiala, Punjab, India
Puneetpal Singh

Department of Human Genetics, Punjabi University, Patiala, Punjab, India

Abstract

Background: The present cross sectional study was carried out on 516 subjects with type 2 diabetes from a tertiary health care hospital to identify the prevalence and predictors of cognitive impairment in diabetes.

Materials and Methods: Cognitive impairment was tested using Mini Mental Scale Examination (MMSE), Trail making tests-A and B (TMT-A and TMT-B). Efficiency of these tests to diagnose cognitive impairment was analysed using reliability index (Cronbach's α = 0.82), which ruled out any internal inconsistency. Of the study participants, 174 (33.73%) met the criteria for cognitive impairment and 342 (66.27%) were having normal cognition. Out of 174, 156 diabetic subjects (89.65 percent) were not diagnosed for neurocognitive impairment prior participation.

Results: Cognitive impairment was observed to be strongly associated with being a woman (P < 0.001), divorced or separated (P = 0.007), sedentary life style (P = 0.001), smoking (P < 0.001), drinking alcohol (P < 0.001), systolic blood pressure >120 mmHg (P = 0.003), triglycerides (TG) >150 mg/dl (P = 0.001), high density lipoprotein <40 mg/dl (P = 0.001), statin use (P = 0.009), waist hip ratio in both males and females (P = 0.001), glucose levels >125 mg/dl (P = 0.005) and duration of diabetes >2 years upto 10 years and more than 10 years (P = 0.001) in univariate testing. In multivariate logistic regression model, being a woman was an independent risk factor for cognitive decline, which is two fold higher (OR 2.00 95%CI 1.25-3.20, P = 0.004) than being a man. Other risk factors like glucose levels > 125 mg/dl, systolic blood pressure >120 mmHg, sedentary life style and duration of diabetes >10 years emerged as independent predictors of cognitive impairment in diabetes.

Conclusion: In conclusion, the present study revealed that higher prevalence of cognitive impairment in diabetes is evident in population of Punjab, especially in women and majority of these patients remain undiagnosed for it.

Cognition - India - prevalence - Punjab - type 2 diabetes

Full Text

References

References
1 Singh P, Khullar S, Singh M, Kaur G, Mastana S. Diabetes to cardiovascular disease: Is depression the potential missing link?. Med Hypotheses 2015; 84: 370-378
2 Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004; 26: 1044-1080
3 Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007; 64: 570-575
4 Saczynski JS, Jónsdóttir MK, Garcia ME, Jonsson PV, Peila R, Eiriksdottir G. et al. Cognitive impairment: An increasingly important complication of type 2 diabetes: The age, gene/environment susceptibility — Reykjavik study. Am J Epidemiol 2008; 168: 1132-1139
5 Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H. et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997; 20: 1388-1395
6 Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16: 93-112
7 Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction. A critical review of published studies?. Diabetes Care 1997; 20: 438-445
8 Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 1996; 39: 1392-1397
9 Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K. et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 1995; 45: 1161-1168
10 Grodstein F, Chen J, Wilson RS, Manson JE. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 2001; 24: 1060-1065
11 Stegmayr B, Asplund K. Diabetes as a risk factor for stroke. A population perspective. Diabetologia 1995; 38: 1061-1068
12 de la Monte SM, Wands JR. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2008; 2: 1101-1113
13 American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 30: S11-S63
14 Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
15 Tsolaki M, Iakovidou V, Navrozidou H, Aminta M, Pantazi T, Kazis A. Hindi mental state examination (HMSE) as a screening test for illiterate demented patients. Int J Geriatr Psychiatry 2000; 15: 662-664
16 Reitan RM. The validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-276
17 Aggarwal OP, Bhasin SK, Sharma AK, Chhabra P, Aggarwal K, Rajoura OP. A new instrument (scale) for measuring the socioeconomic status of a family: Preliminary study. Indian J Community Med 2005; 30: 111-114
18 Ho SC, Woo J, Sham A, Chan SG, Yu AL. A 3-year follow-up study of social, lifestyle and health predictors of cognitive impairment in a Chinese older cohort. Int J Epidemiol 2001; 30: 1389-1396
19 Irvine K, Laws KR, Gale TM, Kondel TK. Greater cognitive deterioration in women than men with Alzheimer's disease: A meta analysis. J Clin Exp Neuropsychol 2012; 34: 989-998
20 Yu ES, Liu WT, Levy P, Zhang MY, Katzman R, Lung CT. et al. Cognitive impairment among elderly adults in Shanghai, China. J Gerontol 1989; 44: S97-S106
21 Solanki RK, Dubey V, Munshi D. Neurocognitive impairment and comorbid depression in patients of diabetes mellitus. Int J Diabetes Dev Ctries 2009; 29: 133-138
22 Allen KV, Frier BM, Strachan MW. The relationship between type 2 diabetes and cognitive dysfunction: Longitudinal studies and their methodological limitations. Eur J Pharmacol 2004; 490: 169-175
23 Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR, Strachan MW. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006; 29: 345-351
24 Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV. et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992
25 Coker LH, Shumaker SA. Type 2 diabetes mellitus and cognition: An understudied issue in women's health. J Psychosom Res 2003; 54: 129-139
26 Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004; 63: 658-663
27 Kalmijn S, Feskens EJ, Launer LJ, Stijnen T, Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38: 1096-1102
28 Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME. et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: The action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009; 32: 221-226
29 Ebady SA, Arami MA, Shafigh MH. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract 2008; 82: 305-309
30 Bruehl H, Wolf OT, Convit A. A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology 2009; 34: 815-821
31 Scott RD, Kritz-Silverstein D, Barrett-Connor E, Wiederholt WC. The association of non-insulin-dependent diabetes mellitus and cognitive function in an older cohort. J Am Geriatr Soc 1998; 46: 1217-1222
32 Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K. et al. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: The ARIC neurocognitive study. Am J Epidemiol 2014; 179: 956-966
33 Böhm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R. et al. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk. Hypertension 2015; 65: 651-661
34 Sink KM, Espeland MA, Rushing J, Castro CM, Church TS, Cohen R. et al. The LIFE Cognition Study: Design and baseline characteristics. Clin Interv Aging 2014; 9: 1425-1436
35 Loprinzi PD, Kane CJ. Exercise and cognitive function: A randomized controlled trial examining acute exercise and free-living physical activity and sedentary effects. Mayo Clin Proc 2015; 90: 450-460
36 Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM. et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000; 160: 174-180
37 Fontbonne A, Berr C, Ducimetière P, Alpérovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: Results of the epidemiology of vascular aging study. Diabetes Care 2001; 24: 366-370
38 Hazari MA, Reddy BR, Uzma N, Kumar BS. Cognitive impairment in type 2 diabetes mellitus. Int J Diabetes Mellit 2015; 3: 19-24